sr141716 has been researched along with Irritable Bowel Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabisiak, A; Fabisiak, N; Fichna, J; Storr, M; Włodarczyk, M | 1 |
| Aveta, T; Borrelli, F; Buono, L; Capasso, R; Di Marzo, V; Izzo, AA; Orlando, P; Pagano, E | 1 |
1 review(s) available for sr141716 and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis.
Topics: Amides; Cannabinoid Receptor Antagonists; Constipation; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Mental Disorders; Pyridines; Rimonabant | 2019 |
1 other study(ies) available for sr141716 and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Topics: Amides; Animals; Colitis; Disease Models, Animal; Ethanolamines; Gastrointestinal Motility; Inflammation; Injections, Intraperitoneal; Irritable Bowel Syndrome; Male; Mice; Mice, Inbred ICR; Mustard Plant; Palmitic Acids; Piperidines; Plant Oils; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; TRPV Cation Channels | 2014 |